Create Biosciences

Executive Summary

Create Biosciences, founded in 2019 and headquartered in Cambridge, Massachusetts, is a contract development and manufacturing organization (CDMO) dedicated to the life sciences sector, with a specialized focus on in-vitro diagnostics (IVD) and molecular biology consumables. The company provides end-to-end services encompassing product development, technology transfer, fill/finish, custom packaging, and distribution. By positioning itself as a trusted operational partner, Create Biosciences enables life sciences companies to manufacture and scale innovative diagnostic products efficiently. The CDMO market, particularly for IVD and molecular biology, has experienced robust growth driven by increased demand for diagnostic testing and personalized medicine. Create Biosciences leverages its comprehensive service offerings to capture a share of this expanding market, though the company remains privately held with limited publicly available financial or operational details. As a relatively early-stage CDMO, Create Biosciences' growth trajectory is contingent upon expanding its client base, scaling manufacturing capacity, and establishing a reputation for quality and reliability. The company operates in a competitive landscape with larger, established CDMOs, but its niche focus on IVD and molecular biology consumables may provide differentiation. Potential upcoming catalysts include securing strategic partnerships with diagnostic developers, achieving regulatory certifications (e.g., ISO 13485) to enhance credibility, or announcing capacity expansions to meet rising demand. While the company's private nature limits visibility, its positioning in a high-growth segment suggests moderate conviction for long-term success, albeit with execution risks typical for private CDMOs.

Upcoming Catalysts (preview)

• Q1 2027ISO 13485 Certification Announcement70% success
• Q4 2026Major Contract Win with a Diagnostic Developer40% success
• TBDCapacity Expansion or New Facility Launch30% success